- Stocks
- Healthcare
- NASDAQ: NUVA

Price (delayed)

$64.61

Market cap

$3.34B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.98

Enterprise value

$4.1B

NUVA's quick ratio has surged by 118% year-on-year and by 32% since the previous quarter

The debt has contracted by 35% from the previous quarter and by 10% YoY

NUVA's EPS has shrunk by 183% YoY and by 36% QoQ

Nuvasive's net income has plunged by 182% YoY and by 34% from the previous quarter

What are the main financial stats of NUVA

Market
Valuations
Earnings

Shares outstanding

51.65M

Market cap

$3.34B

Enterprise value

$4.1B

Price to earnings (P/E)

N/A

Price to book (P/B)

3.97

Price to sales (P/S)

3.13

EV/EBIT

3,478.07

EV/EBITDA

28.56

EV/Sales

3.86

Revenue

$1.06B

EBIT

$1.18M

EBITDA

$143.58M

Free cash flow

$109.64M

Per share
Balance sheet
Liquidity

EPS

-$0.98

Free cash flow per share

$2.13

Book value per share

$16.26

Revenue per share

$20.67

TBVPS

$23.98

Total assets

$2.16B

Total liabilities

$1.33B

Debt

$998.96M

Equity

$835.39M

Working capital

$556.68M

Debt to equity

1.2

Current ratio

3.48

Quick ratio

1.96

Net debt/EBITDA

5.32

Margins
Efficiency
Dividend

EBITDA margin

13.5%

Gross margin

69.7%

Net margin

-4.7%

Operating margin

2.1%

Return on assets

-2%

Return on equity

-5.6%

Return on invested capital

0.1%

Return on capital employed

0.1%

Return on sales

0.1%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Nuvasive stock price performed over time

Intraday

1%

1 week

1.02%

1 month

-5.21%

1 year

11.55%

YTD

14.7%

QTD

-4.68%

How have Nuvasive's revenue and profit performed over time

Revenue

$1.06B

Gross profit

$740.37M

Operating income

$22.32M

Net income

-$49.96M

Gross margin

69.7%

Net margin

-4.7%

The net margin has plunged by 189% YoY and by 34% from the previous quarter

Nuvasive's net income has plunged by 182% YoY and by 34% from the previous quarter

The company's operating income has shrunk by 83% YoY and by 42% QoQ

NUVA's operating margin has dropped by 82% year-on-year and by 42% since the previous quarter

What is Nuvasive's growth rate over time

What is Nuvasive stock price valuation

P/E

N/A

P/B

3.97

P/S

3.13

EV/EBIT

3,478.07

EV/EBITDA

28.56

EV/Sales

3.86

NUVA's EPS has shrunk by 183% YoY and by 36% QoQ

NUVA's price to book (P/B) is 20% more than its last 4 quarters average of 3.3

The equity has contracted by 9% from the previous quarter and by 6% YoY

The price to sales (P/S) is 16% higher than the last 4 quarters average of 2.7 and 4.3% higher than the 5-year quarterly average of 3.0

Nuvasive's revenue has decreased by 8% YoY

How efficient is Nuvasive business performance

The company's return on equity has shrunk by 181% YoY and by 37% QoQ

The return on assets has dropped by 163% year-on-year and by 33% since the previous quarter

NUVA's ROS has shrunk by 99% YoY and by 95% QoQ

The company's return on invested capital has shrunk by 99% YoY and by 93% QoQ

What is NUVA's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for NUVA.

How did Nuvasive financials performed over time

The total assets is 63% greater than the total liabilities

NUVA's current ratio has surged by 158% year-on-year and by 86% since the previous quarter

NUVA's quick ratio has surged by 118% year-on-year and by 32% since the previous quarter

The debt is 20% more than the equity

The debt has contracted by 35% from the previous quarter and by 10% YoY

NUVA's debt to equity is down by 28% since the previous quarter and by 4.8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.